a recognized leader and pioneer in smart infant monitoring technology, today announced a first-of-its-kind partnership with Locus Health, a highly regarded provider of remote patient monitoring (RPM) solutions for pediatric care. This groundbreaking collaboration integrates clinical data from Owlet’s FDA-cleared prescription pulse oximetry device, BabySat®, directly into the Locus Health platform. By connecting continuous, real-time biometric insights with established clinical workflows, the initiative is designed to enhance visibility for care teams, improve care continuity for vulnerable infants, and support families during the critical transition from hospital to home.
The partnership represents an important milestone for Owlet, marking the company’s inaugural enterprise-level collaboration focused exclusively on infant clinical monitoring beyond the traditional consumer nursery environment. By making targeted, clinically actionable data available through Locus Health’s secure RPM interface, clinicians can now more easily track infant vital signs, monitor changing health patterns, and make timely decisions—all without creating added burdens for caregivers or disrupting existing provider processes.
Supporting Families During the Transition From Hospital to Home
Each year, an estimated 500,000 infants in the United States are discharged from neonatal and pediatric intensive care units (NICUs and PICUs) and return home with ongoing medical needs. Many of these infants require specialized oversight due to conditions such as congenital heart disease, chronic lung disease, persistent respiratory vulnerabilities, arrhythmias, and other complex health challenges. For these families, the transition from hospital to home can be emotionally demanding and medically overwhelming, as caregivers work to follow clinical guidance while adjusting to the realities of day-to-day infant care.
Owlet’s partnership with Locus Health aims squarely at addressing these challenges. By integrating BabySat data into Locus Health’s platform, care teams can maintain a continuous connection with at-risk infants long after discharge. This extended oversight helps ensure that caregivers are not navigating the experience alone. Instead, families receive ongoing support while clinicians are equipped with the precise data they need to identify concerning trends, intervene early, and guide parents through post-discharge care.
“For families and healthcare systems alike, the transition from hospital to home represents both a challenge and a tremendous opportunity to improve outcomes,” said Jonathan Harris, Owlet’s President and CEO. “By integrating Owlet’s technology with Locus Health, we’re extending our mission beyond the nursery by connecting our proven monitoring capabilities directly into clinical workflows. Together, we’re helping hospitals scale connected care and supporting families with the confidence and continuity they deserve.”
Harris emphasized that this collaboration is central to Owlet’s broader vision: to support infant health wherever care occurs and to strengthen the connection between care teams and families through accessible, data-driven insights.
The Importance of Clinician Oversight in Home Monitoring
While consumer infant monitoring tools have become increasingly popular, medically vulnerable infants require clinically validated solutions that seamlessly interface with professional oversight. BabySat—the first FDA-cleared pulse oximetry monitor designed specifically for infants and intended for prescription use—was engineered to meet these needs. It measures key vitals including oxygen saturation (SpO₂) and pulse rate, providing continuous biometric data that is essential for monitoring infants with complex conditions.
The integration with Locus Health elevates BabySat’s value by placing its data directly into systems that clinicians use daily. This eliminates the need for separate applications, manual reporting, or reliance on caregiver interpretation. Instead, BabySat delivers high-frequency, automated updates directly to care teams, enabling more accurate and timely assessments.
Andy Archer, Co-Founder and CEO of Locus Health, underscored the significance of bringing together Owlet’s clinical monitoring capabilities with Locus Health’s longstanding expertise in remote pediatric care management.
“Locus Health has long been a leader in remote care management software for vulnerable pediatric patients, their families, and hospital care teams,” Archer said. “Our outcomes-based solutions for populations like congenital heart disease and neonatal ICU patients will be further enhanced with a partner like Owlet, providing vital biometric data through the Locus platform to care teams that increasingly need both timely insights and enhanced workflow efficiency.”
For clinicians, the benefits are twofold: increased access to data and improved integration within existing hospital systems. Because BabySat data feeds seamlessly into the Locus Health interface, providers can evaluate vitals within the same dashboards and analytics tools used for other remote monitoring programs, improving continuity and reducing the risk of oversight.
Reducing Workload, Enhancing Accuracy, and Improving Safety
One key advantage of the integration is the elimination of manual data entry. Historically, parents and caregivers may have needed to track and report key infant metrics, a process that is time-consuming, error-prone, and often stressful for families already adjusting to caregiving at home. The new connectivity ensures that accurate, real-time data reaches clinical teams without requiring parents to submit readings or recall details during check-ins.
This automation minimizes transcription errors, enhances data reliability, and supports timely clinical decision-making. With early trend detection—such as dropping oxygen saturation levels, rising heart rate, or inconsistent patterns—healthcare providers are better positioned to identify potential complications before they escalate.
Moreover, because the integration supports workflow efficiency, clinicians can scale RPM programs without significantly expanding staff workloads. This efficiency is essential for healthcare systems seeking to improve care delivery while managing limited resources.
Empowering Families Through Technology and Connected Care
Beyond clinical benefits, the partnership directly supports families who often face significant emotional strain during the newborn care transition—especially when caring for medically fragile infants. By knowing that their infant’s vitals are being continuously monitored by professionals, parents gain added reassurance and peace of mind. The combination of reliable at-home technology and ongoing clinical oversight helps reduce anxiety, build caregiver confidence, and strengthen communication channels between families and care providers.
Dean Demitropoulos, Senior Director of Business Development at Owlet, highlighted the broader mission behind the collaboration.
“Owlet has monitored more than 2.5 million babies, equipping parents and caregivers with clinically proven, reliable tools to track Baby’s key vitals,” Demitropoulos said. “Our growing footprint in the medical space, and collaboration with a pediatric market leader like Locus, underscores our vision to make health insights accessible at home for infants that require monitoring, bringing families and care teams together through connectivity.”
The partnership represents a meaningful evolution for Owlet as the company advances deeper into clinical care ecosystems. By granting hospitals, clinicians, and health systems access to BabySat data through trusted platforms like Locus Health, Owlet is expanding its role from a consumer technology brand to a genuine partner in pediatric healthcare delivery.
Advancing the Future of Infant Remote Monitoring
As healthcare continues to shift toward hybrid and home-based care models, the demand for connected, data-driven monitoring tools is rising. The Owlet–Locus Health partnership aligns with this industry movement by offering a blueprint for how innovative RPM solutions can be scaled for high-risk pediatric populations.
By combining medically validated home monitoring with established clinical systems, the collaboration strengthens the circle of care between hospitals and families. It demonstrates how technology, when thoughtfully integrated, can improve outcomes, empower caregivers, and support clinicians in delivering proactive, continuous care.
The partnership stands as a milestone for both companies—and a meaningful advancement in the future of connected infant health management.
About Owlet, Inc.
Owlet, Inc. (NYSE: OWLT), a leading pediatric health platform, is the only company in the world to offer U.S. FDA-cleared and internationally medically-certified wearable pediatric monitors, delivering hospital-grade technology directly in the home. Our award-winning pediatric products and innovative software combine clinically tested monitoring systems, an integrated video platform, and a simple, easy-to-use app, providing parents with real-time health insights to stay informed on their child’s well-being, support restful sleep, and provide peace of mind anywhere. Since 2012, more than 2.5 million parents have trusted Owlet to monitor their children’s well-being and sleep. This adoption has fueled one of the largest collections of pediatric health and sleep data in the world, powering innovations that bridge the critical gap between hospital and home. Owlet is driving a new standard in pediatric wellness by pairing advanced medical technology with consumer-friendly design. Our mission is simple yet ambitious: to give every baby and every family the best possible start in life.
About Locus Health
Locus is making the promise of remote patient monitoring and electronic medical record integration a reality for a wide range of populations, supporting care teams’ ability to monitor patients and provide coordinated support. The Locus platform is used at many health systems across the US and in Canada, including multiple top Children’s Hospitals, and has been developed in part through a Small Business Innovation (SBIR) Award by the National Cancer Institute (NCI). For more information on our remote care management solution and to request a demo
source link: https://www.businesswire.com
